David Fortune, MD
Otolaryngology · Hermitage, TNNPI 1245274778
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $238,581 of the $298,284 with a category attached, or 80.0%. Stryker accounts for 63.7% of it on its own, with 25 other manufacturers making up the rest. Among otolaryngology clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 598 payments — averaging $498.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$190K
- Aerin Medical Inc.$66K
- Acclarent, Inc$17K
- Integra Lifesciences Corporation$14K
- Smith+Nephew$7K
- Sanofi$624
- plus $2K from 20 others
What the payments were for
- Consulting fees$238,58180%
- Speaking & faculty fees$4,9502%
- Travel & lodging$41,41614%
- Food & beverage$13,3034%
- Education$340%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 315 | $190,124 |
| Aerin Medical Inc. | 102 | $66,418 |
| Acclarent, Inc | 25 | $16,885 |
| Integra Lifesciences Corporation | 16 | $14,354 |
| Smith+Nephew | 16 | $7,398 |
| Sanofi | 24 | $624 |
| Regeneron Healthcare Solutions, Inc. | 20 | $498 |
| GSK | 19 | $355 |
| Medtronic | 5 | $337 |
| Intersect ENT, Inc. | 7 | $240 |
| Novartis | 11 | $173 |
| Inspire Medical Systems, Inc. | 2 | $169 |
| Optinose US, Inc. | 7 | $144 |
| Genentech USA, Inc. | 7 | $131 |
| Kaleo, Inc. | 6 | $106 |
| AstraZeneca | 5 | $86 |
| Alk-abello, Inc | 2 | $43 |
| Amgen | 1 | $34 |
| Neurent Medical Limited | 1 | $24 |
| Pfizer | 1 | $23 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $22 |
| Hologic Sales And Service, LLC | 1 | $21 |
| Paratek Pharmaceuticals, Inc. | 1 | $19 |
| Baxter Healthcare | 1 | $19 |
| Hikma Pharmaceuticals USA | 1 | $18 |
| Phadia US Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENTELLUS - XPRESS ENT DILATION SYSTEM$104,889
- XPRESS ENT DILATION SYSTEM$73,210
- VIVAER STYLUS$64,954
- CLARIFIX CRYOTHERAPY DEVICE$55,721
- SCOPIS ENT$51,416
- TGS GUIDEWIRE$47,600
- LATERA$43,226
- Coblation$17,055
- Acclarent Aera$13,417
- ACCLARENT Balloon Inflation Device$13,373
- Inspira Air$11,400
- SHAVER SYSTEM$11,375
- N/A$5,950
- Halo$4,950
- 1688$4,900
- CYCLONE SINONASAL SUCTION/IRRIGATION SYSTEM$3,850
- XEROGEL NASAL/EPISTAXIS 2 PACK$3,850
- ORTHOMAP$2,713
- RHINAER STYLUS$2,080
- INTEGRA$1,931
How this compares
$298,284 in reported general payments places this provider in the 95th percentile of 191 otolaryngology providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Epinephrine | 32 | $6,795 |
| Azelastine Hcl | 116 | $4,028 |
| Ipratropium Bromide | 119 | $3,578 |
| Fluticasone Propionate | 112 | $2,401 |
| Montelukast Sodium | 137 | $2,080 |
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 11 | $1,387 |
| Cefdinir | 52 | $1,046 |
| Dexamethasone Sodium Phosphate | 13 | $457 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 23 | $452 |
| Levocetirizine Dihydrochloride | 35 | $361 |
| Famotidine | 19 | $261 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 16 | $217 |
| Nystatin | 11 | $160 |
| Triamcinolone Acetonide | 43 | $153 |
| Prednisone | 33 | $140 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Hikma Pharmaceuticals USAEpinephrine | $18 | $6,79532 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 191 otolaryngology providers in Tennessee.
Other otolaryngology in Hermitage
- Grady BryantHermitage$74K
- Amit PatelHermitage$11K
- Justin MorganHermitage$6K
- Robert FrankHermitage$4K
- Rakesh ChandraNashville$381K
- Marion GillespieMemphis$67K
- Clyde MathisonFarragut$66K
- Dean KlugGermantown$37K
- Michael TopfNashville$36K
- John GleysteenMemphis$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.